Surgery: Minimally invasive esophagectomy

Hiroya Takeuchi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). Extended mediastinal lymphadenectomy including the upper mediastinal nodes along the bilateral recurrent laryngeal nerves (RLNs) is considered as a standard surgery for thoracic esophageal squamous cell carcinoma in Japan. Nowadays, precise upper mediastinal lymphadenectomy along the bilateral RLNs is also feasible, even with thoracoscopic approaches. However, there have been a limited number of prospective multicenter trials to verify the feasibility and benefits of MIE to date. Comparison of the left lateral decubitus position with the prone position also should be assessed as appropriate positioning for MIE, with regard to precise upper mediastinal lymphadenectomy along the bilateral RLNs for esophageal squamous cell carcinoma. Furthermore, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no randomized controlled trials to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer. Although several studies have emphasized that robot-assisted thoracoscopic esophagectomy is safe and feasible, the superiority of robot-assisted thoracoscopic esophagectomy compared with conventional thoracoscopic esophagectomy should be carefully evaluated because robot-assisted thoracoscopic esophagectomy is not comparable with conventional MIE in terms of the cost of a surgery.

Original languageEnglish
Title of host publicationEsophageal Squamous Cell Carcinoma: Diagnosis and Treatment
PublisherSpringer Japan
Pages149-164
Number of pages16
ISBN (Print)9784431549772, 9784431549765
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Esophagectomy
Minimally Invasive Surgical Procedures
Recurrent Laryngeal Nerve
Lymph Node Excision
Esophageal Neoplasms
Prone Position
Thoracoscopy
Thoracic Surgery
Multicenter Studies
Meta-Analysis

Keywords

  • Decubitus
  • Esophageal cancer
  • Laparoscopy
  • Prone
  • Robotic surgery
  • Squamous cell carcinoma
  • Thoracoscopy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Takeuchi, H. (2015). Surgery: Minimally invasive esophagectomy. In Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment (pp. 149-164). Springer Japan. https://doi.org/10.1007/978-4-431-54977-2_9

Surgery : Minimally invasive esophagectomy. / Takeuchi, Hiroya.

Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment. Springer Japan, 2015. p. 149-164.

Research output: Chapter in Book/Report/Conference proceedingChapter

Takeuchi, H 2015, Surgery: Minimally invasive esophagectomy. in Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment. Springer Japan, pp. 149-164. https://doi.org/10.1007/978-4-431-54977-2_9
Takeuchi H. Surgery: Minimally invasive esophagectomy. In Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment. Springer Japan. 2015. p. 149-164 https://doi.org/10.1007/978-4-431-54977-2_9
Takeuchi, Hiroya. / Surgery : Minimally invasive esophagectomy. Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment. Springer Japan, 2015. pp. 149-164
@inbook{46f6c5ca407d4661bc44220ed648425d,
title = "Surgery: Minimally invasive esophagectomy",
abstract = "Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). Extended mediastinal lymphadenectomy including the upper mediastinal nodes along the bilateral recurrent laryngeal nerves (RLNs) is considered as a standard surgery for thoracic esophageal squamous cell carcinoma in Japan. Nowadays, precise upper mediastinal lymphadenectomy along the bilateral RLNs is also feasible, even with thoracoscopic approaches. However, there have been a limited number of prospective multicenter trials to verify the feasibility and benefits of MIE to date. Comparison of the left lateral decubitus position with the prone position also should be assessed as appropriate positioning for MIE, with regard to precise upper mediastinal lymphadenectomy along the bilateral RLNs for esophageal squamous cell carcinoma. Furthermore, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no randomized controlled trials to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer. Although several studies have emphasized that robot-assisted thoracoscopic esophagectomy is safe and feasible, the superiority of robot-assisted thoracoscopic esophagectomy compared with conventional thoracoscopic esophagectomy should be carefully evaluated because robot-assisted thoracoscopic esophagectomy is not comparable with conventional MIE in terms of the cost of a surgery.",
keywords = "Decubitus, Esophageal cancer, Laparoscopy, Prone, Robotic surgery, Squamous cell carcinoma, Thoracoscopy",
author = "Hiroya Takeuchi",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-4-431-54977-2_9",
language = "English",
isbn = "9784431549772",
pages = "149--164",
booktitle = "Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment",
publisher = "Springer Japan",

}

TY - CHAP

T1 - Surgery

T2 - Minimally invasive esophagectomy

AU - Takeuchi, Hiroya

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). Extended mediastinal lymphadenectomy including the upper mediastinal nodes along the bilateral recurrent laryngeal nerves (RLNs) is considered as a standard surgery for thoracic esophageal squamous cell carcinoma in Japan. Nowadays, precise upper mediastinal lymphadenectomy along the bilateral RLNs is also feasible, even with thoracoscopic approaches. However, there have been a limited number of prospective multicenter trials to verify the feasibility and benefits of MIE to date. Comparison of the left lateral decubitus position with the prone position also should be assessed as appropriate positioning for MIE, with regard to precise upper mediastinal lymphadenectomy along the bilateral RLNs for esophageal squamous cell carcinoma. Furthermore, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no randomized controlled trials to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer. Although several studies have emphasized that robot-assisted thoracoscopic esophagectomy is safe and feasible, the superiority of robot-assisted thoracoscopic esophagectomy compared with conventional thoracoscopic esophagectomy should be carefully evaluated because robot-assisted thoracoscopic esophagectomy is not comparable with conventional MIE in terms of the cost of a surgery.

AB - Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). Extended mediastinal lymphadenectomy including the upper mediastinal nodes along the bilateral recurrent laryngeal nerves (RLNs) is considered as a standard surgery for thoracic esophageal squamous cell carcinoma in Japan. Nowadays, precise upper mediastinal lymphadenectomy along the bilateral RLNs is also feasible, even with thoracoscopic approaches. However, there have been a limited number of prospective multicenter trials to verify the feasibility and benefits of MIE to date. Comparison of the left lateral decubitus position with the prone position also should be assessed as appropriate positioning for MIE, with regard to precise upper mediastinal lymphadenectomy along the bilateral RLNs for esophageal squamous cell carcinoma. Furthermore, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no randomized controlled trials to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer. Although several studies have emphasized that robot-assisted thoracoscopic esophagectomy is safe and feasible, the superiority of robot-assisted thoracoscopic esophagectomy compared with conventional thoracoscopic esophagectomy should be carefully evaluated because robot-assisted thoracoscopic esophagectomy is not comparable with conventional MIE in terms of the cost of a surgery.

KW - Decubitus

KW - Esophageal cancer

KW - Laparoscopy

KW - Prone

KW - Robotic surgery

KW - Squamous cell carcinoma

KW - Thoracoscopy

UR - http://www.scopus.com/inward/record.url?scp=84943414004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943414004&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-54977-2_9

DO - 10.1007/978-4-431-54977-2_9

M3 - Chapter

AN - SCOPUS:84943414004

SN - 9784431549772

SN - 9784431549765

SP - 149

EP - 164

BT - Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment

PB - Springer Japan

ER -